Northern Trust’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-22,594
| Closed | -$42.7K | – | 4517 |
|
|
2025
Q3 | $42.7K | Buy |
+22,594
| New | +$32.5K | ﹤0.01% | 4301 |
|
|
2024
Q3 | – | Sell |
-8,606
| Closed | -$68.1K | – | 4436 |
|
|
2024
Q2 | $68.1K | Sell |
8,606
-7
| -0.1% | -$63 | ﹤0.01% | 4143 |
|
|
2024
Q1 | $117K | Buy |
8,613
+1,367
| +19% | +$16.2K | ﹤0.01% | 4036 |
|
|
2023
Q4 | $78.3K | Hold |
7,246
| – | – | ﹤0.01% | 4158 |
|
|
2023
Q3 | $47.1K | Hold |
7,246
| – | – | ﹤0.01% | 4182 |
|
|
2023
Q2 | $130K | Sell |
7,246
-23
| -0.3% | -$536 | ﹤0.01% | 3965 |
|
|
2023
Q1 | $171K | Buy |
7,269
+337
| +5% | +$8.52K | ﹤0.01% | 3913 |
|
|
2022
Q4 | $173K | Hold |
6,932
| – | – | ﹤0.01% | 3930 |
|
|
2022
Q3 | $220K | Buy |
6,932
+566
| +9% | +$22.2K | ﹤0.01% | 3835 |
|
|
2022
Q2 | $251K | Hold |
6,366
| – | – | ﹤0.01% | 3806 |
|
|
2022
Q1 | $256K | Sell |
6,366
-250
| -4% | -$9.2K | ﹤0.01% | 4030 |
|
|
2021
Q4 | $334K | Hold |
6,616
| – | – | ﹤0.01% | 3975 |
|
|
2021
Q3 | $430K | Buy |
6,616
+176
| +3% | +$7.59K | ﹤0.01% | 3821 |
|
|
2021
Q2 | $250K | Hold |
6,440
| – | – | ﹤0.01% | 4059 |
|
|
2021
Q1 | $338K | Buy |
6,440
+933
| +17% | +$62.6K | ﹤0.01% | 3940 |
|
|
2020
Q4 | $374K | Sell |
5,507
-103
| -2% | -$4.77K | ﹤0.01% | 3796 |
|
|
2020
Q3 | $215K | Sell |
5,610
-25
| -0.4% | -$994 | ﹤0.01% | 3804 |
|
|
2020
Q2 | $218K | Sell |
5,635
-366
| -6% | -$14K | ﹤0.01% | 3738 |
|
|
2020
Q1 | $180K | Buy |
6,001
+1,233
| +26% | +$74.4K | ﹤0.01% | 3704 |
|
|
2019
Q4 | $542K | Buy |
4,768
+32
| +0.7% | +$1.85K | ﹤0.01% | 3538 |
|
|
2019
Q3 | $149K | Hold |
4,736
| – | – | ﹤0.01% | 3835 |
|
|
2019
Q2 | $203K | Buy |
4,736
+1,097
| +30% | +$52.7K | ﹤0.01% | 3821 |
|
|
2019
Q1 | $198K | Sell |
3,639
-14
| -0.4% | -$754 | ﹤0.01% | 3784 |
|
|
2018
Q4 | $109K | Buy |
3,653
+582
| +19% | +$22.8K | ﹤0.01% | 3901 |
|
|
2018
Q3 | $141K | Hold |
3,071
| – | – | ﹤0.01% | 3953 |
|
|
2018
Q2 | $67K | Sell |
3,071
-10,055
| -77% | -$290K | ﹤0.01% | 4078 |
|
|
2018
Q1 | $502K | Buy |
13,126
+355
| +3% | +$18.8K | ﹤0.01% | 3566 |
|
|
2017
Q4 | $741K | Sell |
12,771
-158
| -1% | -$10.2K | ﹤0.01% | 3479 |
|
|
2017
Q3 | $854K | Buy |
12,929
+1,343
| +12% | +$89.6K | ﹤0.01% | 3470 |
|
|
2017
Q2 | $980K | Buy |
+11,586
| New | +$1.56M | ﹤0.01% | 3448 |
|
Other funds holding MTNB
DS
HIW
XT
Northern Trust's MTNB Position: Q4 2025 in Review
Northern Trust sold out of Matinas BioPharma (MTNB) in Q4 2025, closing a stake of 22,594 shares — an estimated $42.7K sold.
Northern Trust first reported a position in MTNB in Q2 2017 and held it in 30 quarters. The position peaked at $980K in Q2 2017. 30 funds tracked by Wall St. Rank hold MTNB as of Q4 2025.
- Northern Trust reported no remaining Matinas BioPharma position as of Q4 2025 after selling out during the quarter.
- Northern Trust sold 22,594 Matinas BioPharma shares in Q4 2025, an estimated $42.7K.
- Northern Trust first reported a position in Matinas BioPharma in Q2 2017 and held it in 30 quarters.
- Northern Trust's Matinas BioPharma position peaked at $980K in Q2 2017.
- 30 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2025.
Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.